✦ LIBER ✦

1238 A phase III randomized comparison of MDL (metoclopramide, dexamethasone, and lorazepam) plus granisetron with MDL alone in the prevention of nausea and vomiting associated with multi-day cisplatin-containing chemotherapy

✍ Scribed by Kang, Y.-K.; Cheon, Y.-K.; Im, Y.-H.; Kim, C.-M.; Lee, J.-O.; Kang, T.-W.

Book ID: 124137623
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 157 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96484-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of transdermal

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

✍ Ralph V. Boccia; Lucio N. Gordan; Gemma Clark; Julian D. Howell; Steven M. Grunb 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

## Purpose A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7 days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral gra

Palonosetron in combination with 1-day v

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

✍ Luigi Celio; Sergio Frustaci; Angela Denaro; Angela Buonadonna; Antonio Ardizzoi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 185 KB